CVE-2024-10035: BG-TEK Informatics Security Technologies CoslatV3 · Code Injection
Affects BG-TEK Informatics Security Technologies CoslatV3Source CVE Database V5
Not known to be exploited · CVSS 9.2 Critical.
Data as of 25 Oct 2026, 19:02 UTC
- EPSS
- 0.8% chance of exploitation in 30 days – higher than 57% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 4 Nov 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-25.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| BG-TEK Informatics Security Technologies CoslatV3 | Affected
| Fixed in– |
AI-suggested
Organizations should consider discontinuing use of this product or isolating affected systems to reduce risk. Employing strict access controls to limit local access may reduce exposure. Monitor for suspicious local activity as a precaution.
Description
Improper Control of Generation of Code ('Code Injection'), Improper Neutralization of Special Elements used in a Command ('Command Injection'), Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in BG-TEK Informatics Security Technologies CoslatV3 allows Command Injection, Privilege Escalation. This issue affects CoslatV3: through 3.1069. NOTE: The vendor was contacted and it was learned that the product is not supported.